Materials · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics

ECL Ecolab SEC Filings & Insider Trading Activity 2026

company
CIK 31462138 filings
S&P 500

ECL at a glance

Ecolab (ECL, SEC CIK 31462) filed its latest 10-K annual report on February 23, 2026, a 10-Q quarterly report on October 29, 2026, an 8-K current report on November 17, 2026 and Form 4 insider filings as recently as November 12, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Ecolab (ECL) reported revenue of $16.1 billion (up 2.2% from FY2024) and net income of $2.1 billion. Diluted EPS was $7.28.
  • As of September 30, 2026, 53 institutional investment managers tracked by SignalX reported holding Ecolab (ECL) shares worth $31.1 billion in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by MacLennan David on November 12, 2026 of 600 shares at $308.13 per share.
  • In the last 90 days, ECL insiders reported 3 open-market purchases ($1.2M) and 0 open-market sales ($0) on Form 4, a net purchase of $1.2M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$16.1B
+2.2% vs prior year
Insiders · 90 days
3 buys · 0 sells
Net +$1.2M
13F holders
53 funds
$31.1B · −1 vs prior quarter
Latest 8-K
Nov 17, 2026
Item 2.05

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Risk Factors

  • ~47% of net sales from outside U.S. with exposure to tariffs, retaliatory trade measures, and currency risk in 170+ countries
  • $8.2B total debt outstanding, ~$1.5B floating rate; 1pp rate increase adds ~$15M annual interest expense
  • U.S. Gulf Coast concentration risk: key raw material source and customer base for Light & Heavy segment, vulnerable to hurricanes and severe weather
  • OECD Pillar Two 15% global minimum tax now effective in multiple jurisdictions; OBBBA interaction creates complex compliance and double-taxation risk
  • AI and ERP upgrade execution risk: ongoing multi-phase ERP rollout plus "One Ecolab" restructuring; failure could cause business disruption and financial losses

Management Discussion & Analysis

  • Revenue $16.1B, up 2% YoY ($339.8M increase); organic sales +3%, driven by pricing and volume across all segments
  • Reported operating margin 17.0% vs 17.8% in 2024; adjusted operating margin 18.0% vs 16.6%, boosted by value pricing and productivity
  • Best segment: Global Institutional & Specialty, organic operating margin 22.8% vs 19.9%; worst: Global Life Sciences, smallest at $706M sales despite margin recovery to 17.1% vs 13.7%
  • Operating cash flow $3.0B vs $2.8B; capex $1.0B; share buybacks $784M; dividends paid $754M; Ovivo Electronics acquired for $1.6B cash
  • One Ecolab restructuring expanded Feb 2026 to $334M total cost targeting $325M annualized savings by 2027; FX exposure and geopolitical risk (Russia/Ukraine ~1% of sales) cited as key risks

Business Overview

  • Global leader in water, hygiene and infection prevention; $16B annual sales, 48,000 associates, 170+ countries, 40 industries
  • Four reportable segments this filing: Global Water, Global Institutional & Specialty, Global Pest Elimination, Global Life Sciences; Life Sciences explicitly elevated as standalone segment
  • Warewashing products grew to 13% of consolidated net sales in 2025, up from 12% in 2024 and 2023: only product line disclosed at 10%+ threshold
  • Capital expenditures for environmental, health and safety projects held steady at ~$62M in 2025 (vs $46M in 2023), with $59M budgeted for 2026
  • Workforce of ~25,000 in sales/service roles plus ~3,000 R&D/digital experts; 43% North America, notable 8% India/Middle East/Africa concentration disclosed

AI summary of the ECL 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes reported from the December 31, 2025 Form 10-K risk factors
  • Carried-forward risk: factors could materially reduce future financial performance
  • Forward-looking statement risk: actual results may differ materially from expectations
  • Disclosure risk: oral presentations and public webcasts may contain forward-looking statements

Management Discussion & Analysis

  • Revenue $4,694.8M, up 13% YoY from $4,165.0M
  • Reported operating margin 17.3% vs 18.3% YoY, organic margin 19.6% vs 18.9%
  • Best segment: Global Life Sciences organic sales up 17% to $215.8M, margin 23.3% vs 18.3%
  • Worst segment: Global Pest Elimination organic margin 20.8% vs 20.9%, down 0.1 percentage points
  • Cash $722.3M, operating cash flow $1,939.1M, acquisitions and affiliate investments $4.7B through nine months
  • Outlook: strong operating cash flow expected, with commodity and logistics cost pressures from geopolitics and energy volatility

AI summary of the ECL 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 17, 2026Full analysis →

Item 2.05: Costs Associated with Exit or Disposal Activities

  • One Ecolab restructuring expanded, targeting global centers of excellence and digital-enabled functional realignment
  • Total restructuring costs $485 million, including $378 million after tax, expected by end of 2030
Filed Oct 27, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Ecolab announced third-quarter 2026 earnings for the period ended September 30, 2026
  • News release and supplemental data available in Exhibits 99.1 and 99.2

Item EX-99.1: Item EX-99.1

  • Q3 sales $4.695B, up 13%, with organic growth accelerating to 7%, signaling broad-based demand and pricing strength
  • Adjusted EPS $2.18, up 5%, despite an approximate 10% CoolIT-related amortization and financing headwind

Item EX-99.2: Item EX-99.2

  • 3Q 2026 sales $4.695B, up 13%, with organic growth accelerating to 7% on 2% volume and 5% pricing
  • Adjusted EPS $2.18, up 5%, despite an approximate 10-point CoolIT amortization and financing headwind
Filed Jul 28, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q2 sales $4.4B, up 10%, with organic growth accelerating to 5%; pricing reached 4% despite Middle East disruptions
  • Adjusted diluted EPS $2.09, up 11%, while reported EPS rose 3% to $1.90; productivity offset commodity inflation

Item 2.02: Results of Operations and Financial Condition

  • Q2 2026 earnings announced for quarter ended June 30, 2026
  • News release furnished as Exhibit 99.1, containing the detailed financial results

Item EX-99.2: Item EX-99.2

  • Q2 2026 sales $4.42B, up 10%; organic growth accelerated to 5%, led by Life Sciences, Pest Elimination and High-Tech
  • Adjusted diluted EPS $2.09, up 11%; organic operating margin expanded 40 bps to 18.8%

AI summaries of ECL 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for ECL

Don't miss the next ECL filing

  • Alerts as it files. A push when ECL files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut ECL, by share count.
  • Ask anything. An AI agent that reads every ECL filing and answers with sources.

ECL alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
MacLennan DavidBuyNov 12, 2026$308.13
Boone Jandeen MFNov 2, 2026$306.35
Mewhorter Bryce LMNov 2, 2026-
Clark Benjamin M.MNov 2, 2026-
Clark Benjamin M.MNov 2, 2026-
Boone Jandeen MMNov 2, 2026-
Mewhorter Bryce LMNov 2, 2026-
Mewhorter Bryce LFNov 2, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$15.7B$16.1B
Operating Income$2.0B$2.8B$2.7B
Net Income$1.4B$2.1B$2.1B
Op. Margin-17.8%17.0%
Net Margin-13.4%12.9%
Balance Sheet
Total Assets-$22.4B$24.7B
Equity-$8.8B$9.8B
ROE-24.1%21.2%
Per Share
EPS-$7.37$7.28
Cash Flow
Operating CF$2.4B$2.8B$3.0B
CapEx$774.8M$994.5M$1.0B

Source: XBRL data in Ecolab (ECL)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate ECL share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
ECL shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202653$31.11B
Q2 202654$30.49B
Q1 202658$28.21B
Q4 202554$27.68B
Q3 202556$30.69B
Q2 202554$27.11B
Q1 202551$19.37B
Q4 202447$14.70B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 427 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

ECL filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KNov 17, 2026Analysis-
4Nov 12, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
10-QOct 29, 2026Analysis
8-KOct 27, 2026Analysis-
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Sep 14, 2026--
4Aug 20, 2026--
4Aug 11, 2026--
10-QAug 6, 2026Analysis
4Aug 5, 2026--

Related Materials companies

All Materials →

ECL SEC filings: frequently asked questions

Are ECL insiders buying or selling?

In the last 90 days, Ecolab (ECL) officers, directors and 10% owners reported 3 open-market purchases worth $1.2 million by 2 insiders and no open-market sales on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold ECL stock?

As of September 30, 2026, the largest Ecolab (ECL) holders among the 13F filers tracked by SignalX were BlackRock ($6.2 billion), JPMorgan Chase & Co ($4.7 billion), Vanguard Capital Management LLC ($4.5 billion), State Street Corp ($3.2 billion), Morgan Stanley ($2.1 billion). 13F-HR reports are filed up to 45 days after each quarter ends.

What was ECL's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Ecolab (ECL) reported revenue of $16.1 billion (up 2.2% from FY2024) and net income of $2.1 billion. Diluted EPS was $7.28. The figures come from the XBRL data in the 10-K.

What are the main risks in ECL's latest 10-K?

In the 10-K filed February 23, 2026, Ecolab (ECL) flagged: ~47% of net sales from outside U.S. with exposure to tariffs, retaliatory trade measures, and currency risk in 170+ countries. $8.2B total debt outstanding, ~$1.5B floating rate; 1pp rate increase adds ~$15M annual interest expense. (AI summary of the Risk Factors section.)

What did ECL report in its latest 8-K?

Ecolab (ECL) filed an 8-K on November 17, 2026 reporting Item 2.05 (Costs Associated with Exit or Disposal Activities). One Ecolab restructuring expanded, targeting global centers of excellence and digital-enabled functional realignment.

What are the latest ECL SEC filings?

Ecolab (ECL) filed its latest 10-K annual report on February 23, 2026, a 10-Q quarterly report on October 29, 2026, an 8-K current report on November 17, 2026 and a Form 4 insider filing on November 12, 2026.

What is ECL's SEC CIK number?

Ecolab (ECL)'s SEC Central Index Key (CIK) is 31462. EDGAR lists every ECL filing under that number.

Ask anything about ECL

The research agent reads ECL's filings, financials, insider trades and 13F holders, then answers with sources.